{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,30]],"date-time":"2026-07-30T06:40:17Z","timestamp":1785393617298,"version":"3.55.0"},"reference-count":40,"publisher":"American Medical Association (AMA)","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA Netw Open"],"DOI":"10.1001\/jamanetworkopen.2020.2051","type":"journal-article","created":{"date-parts":[[2020,4,3]],"date-time":"2020-04-03T15:39:50Z","timestamp":1585928390000},"page":"e202051","source":"Crossref","is-referenced-by-count":13,"title":["Association of Medicare Part D Benzodiazepine Coverage Expansion With Changes in Fall-Related Injuries and Overdoses Among Medicare Advantage Beneficiaries"],"prefix":"10.1001","volume":"3","author":[{"given":"Donovan T.","family":"Maust","sequence":"first","affiliation":[{"name":"Injury Prevention Center, University of Michigan, Ann Arbor"},{"name":"Department of Psychiatry, University of Michigan Medical School, Ann Arbor"},{"name":"Center for Clinical Management Research, Veterans Affairs Ann Arbor Healthcare System, Ann Arbor, Michigan"},{"name":"Institute for Healthcare Policy and Innovation, University of Michigan, Ann Arbor"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lewei Allison","family":"Lin","sequence":"additional","affiliation":[{"name":"Injury Prevention Center, University of Michigan, Ann Arbor"},{"name":"Department of Psychiatry, University of Michigan Medical School, Ann Arbor"},{"name":"Center for Clinical Management Research, Veterans Affairs Ann Arbor Healthcare System, Ann Arbor, Michigan"},{"name":"Institute for Healthcare Policy and Innovation, University of Michigan, Ann Arbor"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jason E.","family":"Goldstick","sequence":"additional","affiliation":[{"name":"Injury Prevention Center, University of Michigan, Ann Arbor"},{"name":"Institute for Healthcare Policy and Innovation, University of Michigan, Ann Arbor"},{"name":"Department of Emergency Medicine, University of Michigan Medical School, Ann Arbor"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rebecca L.","family":"Haffajee","sequence":"additional","affiliation":[{"name":"Injury Prevention Center, University of Michigan, Ann Arbor"},{"name":"Department of Health Management and Policy, University of Michigan School of Public Health, Ann Arbor"},{"name":"Economics, Sociology, and Statistics Department, RAND Corporation, Boston, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rebecca","family":"Brownlee","sequence":"additional","affiliation":[{"name":"Department of Psychiatry, University of Michigan Medical School, Ann Arbor"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amy S. B.","family":"Bohnert","sequence":"additional","affiliation":[{"name":"Injury Prevention Center, University of Michigan, Ann Arbor"},{"name":"Department of Psychiatry, University of Michigan Medical School, Ann Arbor"},{"name":"Center for Clinical Management Research, Veterans Affairs Ann Arbor Healthcare System, Ann Arbor, Michigan"},{"name":"Institute for Healthcare Policy and Innovation, University of Michigan, Ann Arbor"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10","published-online":{"date-parts":[[2020,4,3]]},"reference":[{"issue":"26","key":"zoi200110r1","doi-asserted-by":"publisher","first-page":"1701","DOI":"10.1056\/NEJM198812293192604","article-title":"Risk factors for falls among elderly persons living in the community.","volume":"319","author":"Tinetti","year":"1988","journal-title":"N Engl J Med"},{"issue":"23","key":"zoi200110r2","doi-asserted-by":"publisher","first-page":"3303","DOI":"10.1001\/jama.1989.03430230088031","article-title":"Benzodiazepines of long and short elimination half-life and the risk of hip fracture.","volume":"262","author":"Ray","year":"1989","journal-title":"JAMA"},{"issue":"7","key":"zoi200110r3","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1001\/jama.2013.272","article-title":"Pharmaceutical overdose deaths, United States, 2010.","volume":"309","author":"Jones","year":"2013","journal-title":"JAMA"},{"issue":"4","key":"zoi200110r4","doi-asserted-by":"publisher","first-page":"686","DOI":"10.2105\/AJPH.2016.303061","article-title":"Increasing benzodiazepine prescriptions and overdose mortality in the United States, 1996-2013.","volume":"106","author":"Bachhuber","year":"2016","journal-title":"Am J Public Health"},{"key":"zoi200110r5","doi-asserted-by":"publisher","first-page":"h2698","DOI":"10.1136\/bmj.h2698","article-title":"Benzodiazepine prescribing patterns and deaths from drug overdose among US veterans receiving opioid analgesics: case-cohort study.","volume":"350","author":"Park","year":"2015","journal-title":"BMJ"},{"key":"zoi200110r6","article-title":"Risk of overdose with exposure to prescription opioids, benzodiazepines, and non-benzodiazepine sedative-hypnotics in adults: a retrospective cohort study.","author":"Cho","journal-title":"J Gen Intern Med"},{"issue":"3","key":"zoi200110r7","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1111\/add.v115.3","article-title":"Trends in opioid use disorder and overdose among opioid-naive individuals receiving an opioid prescription in Massachusetts from 2011 to 2014.","volume":"115","author":"Burke","year":"2020","journal-title":"Addiction"},{"key":"zoi200110r8","doi-asserted-by":"publisher","first-page":"j760","DOI":"10.1136\/bmj.j760","article-title":"Association between concurrent use of prescription opioids and benzodiazepines and overdose: retrospective analysis.","volume":"356","author":"Sun","year":"2017","journal-title":"BMJ"},{"issue":"2","key":"zoi200110r9","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2018.0217","article-title":"The burden of opioid-related mortality in the United States.","volume":"1","author":"Gomes","year":"2018","journal-title":"JAMA Netw Open"},{"issue":"11","key":"zoi200110r10","doi-asserted-by":"publisher","first-page":"1208","DOI":"10.1001\/jamapsychiatry.2019.2563","article-title":"Opioid and benzodiazepine coprescribing in the United States before and after US Food and Drug Administration boxed warning.","volume":"76","author":"Zhang","year":"2019","journal-title":"JAMA Psychiatry"},{"issue":"5","key":"zoi200110r11","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1016\/j.amepre.2019.06.007","article-title":"An examination of concurrent opioid and benzodiazepine prescribing in 9 states, 2015.","volume":"57","author":"Guy","year":"2019","journal-title":"Am J Prev Med"},{"issue":"4","key":"zoi200110r12","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1001\/jamainternmed.2015.8581","article-title":"Changes in prescription and over-the-counter medication and dietary supplement use among older adults in the United States, 2005 vs 2011.","volume":"176","author":"Qato","year":"2016","journal-title":"JAMA Intern Med"},{"issue":"9","key":"zoi200110r13","doi-asserted-by":"publisher","first-page":"1143","DOI":"10.1176\/appi.ps.56.9.1143","article-title":"The exclusion of benzodiazepine coverage in Medicare: simple steps for avoiding a public health crisis.","volume":"56","author":"Bambauer","year":"2005","journal-title":"Psychiatr Serv"},{"issue":"10","key":"zoi200110r14","doi-asserted-by":"publisher","first-page":"1191","DOI":"10.1176\/ps.2008.59.10.1191","article-title":"The impact of Medicare Part D on psychotropic utilization and financial burden for community-based seniors.","volume":"59","author":"Chen","year":"2008","journal-title":"Psychiatr Serv"},{"issue":"7","key":"zoi200110r15","doi-asserted-by":"publisher","first-page":"1292","DOI":"10.1111\/jgs.2012.60.issue-7","article-title":"Effect of Medicare Part D benzodiazepine exclusion on psychotropic use in benzodiazepine users.","volume":"60","author":"Ong","year":"2012","journal-title":"J Am Geriatr Soc"},{"issue":"4","key":"zoi200110r17","doi-asserted-by":"publisher","first-page":"616","DOI":"10.1111\/jgs.2012.60.issue-4","article-title":"American Geriatrics Society updated Beers Criteria for potentially inappropriate medication use in older adults.","volume":"60","author":"American Geriatrics Society 2012 Beers Criteria Update Expert Panel","year":"2012","journal-title":"J Am Geriatr Soc"},{"issue":"8","key":"zoi200110r18","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1001\/archinternmed.2010.57","article-title":"Medicare Part D\u2019s exclusion of benzodiazepines and fracture risk in nursing homes.","volume":"170","author":"Briesacher","year":"2010","journal-title":"Arch Intern Med"},{"issue":"2","key":"zoi200110r19","doi-asserted-by":"publisher","first-page":"96","DOI":"10.7326\/0003-4819-146-2-200701160-00004","article-title":"Effect of New York State regulatory action on benzodiazepine prescribing and hip fracture rates.","volume":"146","author":"Wagner","year":"2007","journal-title":"Ann Intern Med"},{"issue":"4","key":"zoi200110r20","doi-asserted-by":"publisher","first-page":"492","DOI":"10.1093\/gerona\/gln043","article-title":"Number and dosage of central nervous system medications on recurrent falls in community elders: the Health, Aging and Body Composition study.","volume":"64","author":"Hanlon","year":"2009","journal-title":"J Gerontol A Biol Sci Med Sci"},{"issue":"10","key":"zoi200110r21","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1001885","article-title":"The Reporting of studies Conducted using Observational Routinely-collected health Data (RECORD) statement.","volume":"12","author":"Benchimol","year":"2015","journal-title":"PLoS Med"},{"issue":"1","key":"zoi200110r22","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s40621-015-0066-z","article-title":"Development of an algorithm to identify fall-related injuries and costs in Medicare data.","volume":"3","author":"Kim","year":"2016","journal-title":"Inj Epidemiol"},{"key":"zoi200110r26","doi-asserted-by":"publisher","first-page":"28","DOI":"10.4088\/JCP.v66n0104","article-title":"Benzodiazepine use, abuse, and dependence.","volume":"66","author":"O\u2019Brien","year":"2005","journal-title":"J Clin Psychiatry"},{"issue":"2","key":"zoi200110r27","doi-asserted-by":"publisher","first-page":"e180919","DOI":"10.1001\/jamanetworkopen.2018.0919","article-title":"Exposure-response association between concurrent opioid and benzodiazepine use and risk of opioid-related overdose in Medicare Part D beneficiaries.","volume":"1","author":"Hernandez","year":"2018","journal-title":"JAMA Netw Open"},{"issue":"4","key":"zoi200110r28","doi-asserted-by":"publisher","first-page":"674","DOI":"10.1111\/jgs.2019.67.issue-4","article-title":"American Geriatrics Society 2019 updated AGS Beers Criteria\u00ae for potentially inappropriate medication use in older adults.","volume":"67","author":"By the 2019 American Geriatrics Society Beers Criteria\u00ae Update Expert Panel","year":"2019","journal-title":"J Am Geriatr Soc"},{"issue":"273","key":"zoi200110r29","first-page":"1","article-title":"Drug overdose deaths in the United States, 1999-2015.","author":"Hedegaard","year":"2017","journal-title":"NCHS Data Brief"},{"issue":"8","key":"zoi200110r30","doi-asserted-by":"publisher","first-page":"843","DOI":"10.1016\/S0531-5565(03)00133-5","article-title":"When drug therapy gets old: pharmacokinetics and pharmacodynamics in the elderly.","volume":"38","author":"Turnheim","year":"2003","journal-title":"Exp Gerontol"},{"issue":"8","key":"zoi200110r31","first-page":"639","article-title":"A systematic review of amnestic and non-amnestic mild cognitive impairment induced by anticholinergic, antihistamine, GABAergic and opioid drugs.","volume":"29","author":"Tannenbaum","year":"2012","journal-title":"Drugs Aging"},{"issue":"3","key":"zoi200110r33","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1097\/JGP.0b013e318190b8ef","article-title":"The epidemiology of substance use and disorders among middle aged and elderly community adults: national survey on drug use and health.","volume":"17","author":"Blazer","year":"2009","journal-title":"Am J Geriatr Psychiatry"},{"issue":"7","key":"zoi200110r34","doi-asserted-by":"publisher","first-page":"1252","DOI":"10.1111\/jgs.2009.57.issue-7","article-title":"Nonprescription use of pain relievers by middle-aged and elderly community-living adults: National Survey on Drug Use and Health.","volume":"57","author":"Blazer","year":"2009","journal-title":"J Am Geriatr Soc"},{"key":"zoi200110r35","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1016\/j.drugalcdep.2016.11.003","article-title":"Demographic trends of binge alcohol use and alcohol use disorders among older adults in the United States, 2005-2014.","volume":"170","author":"Han","year":"2017","journal-title":"Drug Alcohol Depend"},{"issue":"12","key":"zoi200110r36","doi-asserted-by":"publisher","first-page":"2630","DOI":"10.1377\/hlthaff.2011.1344","article-title":"New risk-adjustment system was associated with reduced favorable selection in Medicare Advantage.","volume":"31","author":"McWilliams","year":"2012","journal-title":"Health Aff (Millwood)"},{"issue":"12","key":"zoi200110r37","doi-asserted-by":"publisher","first-page":"2618","DOI":"10.1377\/hlthaff.2012.0345","article-title":"Steps to reduce favorable risk selection in Medicare Advantage largely succeeded, boding well for health insurance exchanges.","volume":"31","author":"Newhouse","year":"2012","journal-title":"Health Aff (Millwood)"},{"issue":"4","key":"zoi200110r38","doi-asserted-by":"publisher","first-page":"524","DOI":"10.1001\/jamainternmed.2018.7639","article-title":"Analysis of drivers of disenrollment and plan switching among Medicare Advantage beneficiaries.","volume":"179","author":"Meyers","year":"2019","journal-title":"JAMA Intern Med"},{"issue":"10","key":"zoi200110r39","doi-asserted-by":"publisher","first-page":"1675","DOI":"10.1377\/hlthaff.2015.0272","article-title":"High-cost patients had substantial rates of leaving Medicare Advantage and joining traditional Medicare.","volume":"34","author":"Rahman","year":"2015","journal-title":"Health Aff (Millwood)"},{"issue":"7","key":"zoi200110r40","doi-asserted-by":"publisher","first-page":"1020","DOI":"10.1001\/jamainternmed.2016.2266","article-title":"Characteristics of decedents in Medicare Advantage and traditional Medicare.","volume":"176","author":"Byhoff","year":"2016","journal-title":"JAMA Intern Med"},{"key":"zoi200110r23","volume-title":"Consensus Recommendations for National and State Poisoning Surveillance","author":"Injury Surveillance Workgroup","year":"2012"},{"key":"zoi200110r32","author":"Soldo","year":"2006"},{"key":"zoi200110r16","unstructured":"Centers for Medicare & Medicaid Services. Transition to Part D coverage of benzodiazepines and barbiturates beginning in 2013. Accessed May 6, 2016. https:\/\/www.cms.gov\/Medicare\/Prescription-Drug-Coverage\/PrescriptionDrugCovContra\/Downloads\/BenzoandBarbituratesin2013.pdf"},{"key":"zoi200110r24","unstructured":"US Food and Drug Administration. FDA Drug Safety Communication: FDA warns about serious risks and death when combining opioid pain or cough medicines with benzodiazepines; requires its strongest warning. August 31, 2016. Accessed May 10, 2019. https:\/\/www.fda.gov\/media\/99761\/download"},{"key":"zoi200110r25","unstructured":"Centers for Medicare & Medicaid Services. Important information about Medicare coverage of drugs under Part B and the new Medicare prescription drug coverage (Part D), and vaccines administered in a physician\u2019s office\u2014the ninth in the MLN Matters series on the new prescription drug plans. Accessed July 23, 2019. https:\/\/www.cms.gov\/outreach-and-education\/medicare-learning-network-mln\/mlnmattersarticles\/downloads\/SE0570.pdf"}],"container-title":["JAMA Network Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jamanetworkopen\/articlepdf\/2763836\/maust_2020_oi_200110.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,4,3]],"date-time":"2020-04-03T15:39:56Z","timestamp":1585928396000},"score":1,"resource":{"primary":{"URL":"https:\/\/jamanetwork.com\/journals\/jamanetworkopen\/fullarticle\/2763836"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,4,3]]},"references-count":40,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2020,4,1]]}},"URL":"https:\/\/doi.org\/10.1001\/jamanetworkopen.2020.2051","relation":{},"ISSN":["2574-3805"],"issn-type":[{"value":"2574-3805","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,4,3]]}}}